Molindone

DRUG2 trials

Sponsors

University of North Carolina, Chapel Hill, Supernus Pharmaceuticals, Inc.

Conditions

Impulsive Aggression Comorbid With ADHD in ChildrenSchizophrenia

Phase 2

Open-Label, Extension Study to 810P202

CompletedNCT01416064

Supernus Pharmaceuticals, Inc.Impulsive Aggression Comorbid With ADHD in Children

Start: 2011-09-30End: 2013-02-28Updated: 2017-05-02

Phase 4

Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)

CompletedNCT00053703

University of North Carolina, Chapel HillSchizophrenia

Start: 2002-02-28End: 2007-05-31Updated: 2014-03-26

Related Papers

Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study

Journal of Child and Adolescent Psychopharmacology2020-07-079 citations

F19. TREATMENT RESPONSE OVER THREE RANDOMIZATIONS IN THE TREATMENT OF EARLY-ONSET SCHIZOPHRENIA SPECTRUM DISORDERS STUDY (TEOSS)

Schizophrenia Bulletin2019-04-01

Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study

Journal of Child and Adolescent Psychopharmacology2018-06-1925 citations

Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.

2012-03-1329 citations

Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.

2010-05-0164 citations